CN110272472A - 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 - Google Patents
一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 Download PDFInfo
- Publication number
- CN110272472A CN110272472A CN201910649716.7A CN201910649716A CN110272472A CN 110272472 A CN110272472 A CN 110272472A CN 201910649716 A CN201910649716 A CN 201910649716A CN 110272472 A CN110272472 A CN 110272472A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- polypeptide
- porphyromonas gingivalis
- acid bacillus
- tool
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
本项发明属于医药应用领域,具体涉及一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用。该多肽的氨基酸序列为:Lys–Ile–Gly–Ile–Asn–Gly–Phe–Gly–Arg–Ile–Gly–Arg–Leu–Val–Leu–Arg,如序列表SEQ ID NO:1所示。本发明所述的抗牙龈卟啉单胞菌及具核酸杆菌多肽适宜制成牙龈卟啉单胞菌及具核酸杆菌感染性疾病药物、漱口水及牙膏添加剂。该多肽对牙龈卟啉单胞菌及具核酸杆菌具有较强的抑制作用,且对人血红细胞毒性极小。
Description
技术领域
本项发明属于医药应用领域,具体涉及一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用。
背景技术
抗菌肽由于抗菌效果好且毒副作用低,近年来已经成为新型抗菌药物研究领域的热点。牙龈卟啉单胞菌及具核酸杆菌是重要的口腔致病菌,在牙周疾病如牙周炎、牙周脓肿等疾病的发生发展过程中发挥着重要作用。因此,有效的杀灭牙龈卟啉单胞菌及具核酸杆菌在牙周疾病的防治中具有重要意义。
发明内容
本发明旨在提供一种抗牙龈卟啉单胞菌及具核酸杆菌多肽,该抗菌肽能够治疗牙龈卟啉单胞菌及具核酸杆菌相关感染,且无毒副作用。
本发明的第一个目的是提供一种抗牙龈卟啉单胞菌及具核酸杆菌多肽,所述多肽的氨基酸序列为:Lys–Ile–Gly–Ile–Asn–Gly–Phe–Gly–Arg–Ile–Gly–Arg–Leu–Val–Leu–Arg,,如序列表SEQ ID NO:1所示。
本发明的第二个目的是提供上述多肽在制备牙龈卟啉单胞菌及具核酸杆菌感染性疾病药物中的应用。
本发明的第三个目的是提供上述多肽在制备漱口水中的应用。
本发明的第四个目的是提供上述多肽在制备牙膏添加剂中的应用。
与现有技术相比,本发明具有如下有效果:
本发明所述的抗牙龈卟啉单胞菌及具核酸杆菌多肽可高效且持久的抑制牙龈卟啉单胞菌及具核酸杆菌,且对人血红细胞毒性极小,具有开发成抗牙龈卟啉单胞菌及具核酸杆菌药物、牙膏添加剂和漱口水的潜力,用于防治牙龈卟啉单胞菌及具核酸杆菌引起的牙周疾病。
附图说明
图1为实施例3中抗牙龈卟啉单胞菌及具核酸杆菌多肽的抑菌效果(A:牙龈卟啉单胞菌不加多肽处理;B:牙龈卟啉单胞菌加多肽处理;C:空白培养基;D具核酸杆菌加多肽处理;E:具核酸杆菌不加多肽处理)。
图2为实施例3中培养时间与OD值的关系图。
图3为实施例4中抗牙龈卟啉单胞菌及具核酸杆菌多肽的溶血活性图。
具体实施方式
下面结合附图和具体实施例对本发明进行详细说明,但不应理解为本发明的限制。如无特殊说明,下述实施例中所用的技术手段为本领域技术人员所熟知的常规手段,下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。
实施例1
抗牙龈卟啉单胞菌及具核酸杆菌多肽的获得
本发明提出的抗菌多肽来源于我们所构建的中药黄蛞蝓多肽序列数据库,其氨基酸序列如下:Lys–Ile–Gly–Ile–Asn–Gly–Phe–Gly–Arg–Ile–Gly–Arg–Leu–Val–Leu–Arg,如序列表SEQ ID NO:1所示。根据所示的氨基酸序列,经吉尔生化(上海)有限公司合成得到对应的抗菌多肽,其纯度>95%。
实施例2
抗牙龈卟啉单胞菌及具核酸杆菌多肽的抑菌活性
将多肽配置成为一定浓度储存备用,以生理盐为稀释液,通过二倍稀释法配置系列梯度的多肽溶液。将对数生长期的待测菌液用新鲜的培养基调整为约105-106CFU/mL用于接种,其中牙龈卟啉单胞菌及具核酸杆菌所用培养基为ATCC Medium 2722,正常菌株所用培养基为LB。分别取上述多肽溶液和菌液100μL加入无菌的96孔细胞培养版中,每个多肽浓度3个平行。37℃恒温培养,牙龈卟啉单胞菌及具核酸杆菌厌氧培养48h,常规菌正常培养18-24h,以肉眼无可见细菌生长的最低多肽浓度为该多肽对检测菌的最小抑菌浓度。
抗牙龈卟啉单胞菌及具核酸杆菌多肽的抗菌活性如表1所示,由表1可以看出,该多肽主要对牙龈卟啉单胞菌和具核酸杆菌具有很好的抗菌活性,其最小抑菌浓度分别为12.5μg/mL和25μg/mL。而在100μg/mL的浓度下对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌和白色念珠菌没有抗菌活性。说明该多肽具有很好的细菌选择性。
表1
实施例3
抗牙龈卟啉单胞菌及具核酸杆菌多肽抑菌效果的有效性
将对数生长期的待测菌液用新鲜的培养基ATCC Medium 2722调整为约105-106CFU/mL,加入抗菌多肽,抗菌多肽终浓度为100μg/mL,不加抗菌多肽为对照。37℃恒温培养,牙龈卟啉单胞菌及具核酸杆菌厌氧培养96h,观测细菌生长情况并检测培养体系OD630吸光值。
抗牙龈卟啉单胞菌及具核酸杆菌多肽的抗菌有效性如图1所示,注:A:牙龈卟啉单胞菌不加多肽处理;B:牙龈卟啉单胞菌加多肽处理;C:空白培养基;D具核酸杆菌加多肽处理;E:具核酸杆菌不加多肽处理。
由图1可以看出,经多肽处理的牙龈卟啉单胞菌(试管B)和具核酸杆菌(试管D)培养了96h后,培养体系依然和培养基对照(试管C)一样为透明的;而未经多肽处理的牙龈卟啉单胞菌(试管A)和具核酸杆菌(试管E)培养了96h后,培养体系为浑浊的。如图2所示,经多肽处理后的培养体系其OD630吸光值在96h依然为基础吸光值。由此可以说明该多肽对牙龈卟啉单胞菌和具核酸杆菌具有很好的抗菌有效性,有效性最少可维持96h,说明该多肽具有持久或者高效的抑菌作用。
实施例4
抗牙龈卟啉单胞菌及具核酸杆菌多肽的溶血活性
采集健康人新鲜血液抗凝血2mL,1000g离心5min,弃血浆收集红细胞。将收集到的红细胞用生理盐洗涤三遍,按2%(V/V)的比例重悬血细胞。在无菌的96孔细胞培养板中加入100μL上述红细胞重悬液,再分别加入不同浓度的多肽溶液,每个多肽浓度设置3个平行。以0.1%Tritonx-100作为完全溶血的阳性对照,以生理盐组作为不溶血的阴性对照。37℃孵育1h,1000g离心10min。离心后将上清转移到新的无菌96孔细胞培养板中,并利用酶标仪检测570nm处的光吸收值,计算多肽的溶血活性。
抗牙龈卟啉单胞菌及具核酸杆菌多肽溶血活性如图3所示,该多肽在800μg/mL的浓度下仅表现出不足2%的溶血活性,说明其毒副作用非常低。
尽管已描述了本发明的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。
序列表
<110> 河南科技大学
<120> 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 16
<212> PRT
<213> 人工序列
<400> 1
Lys Ile Gly Ile Asn Gly Phe Gly Arg Ile Gly Arg Leu Val Leu Arg
1 5 10 15
Claims (4)
1.一种抗牙龈卟啉单胞菌及具核酸杆菌多肽,其特征在于,所述多肽的氨基酸序列为:Lys–Ile–Gly–Ile–Asn–Gly–Phe–Gly–Arg–Ile–Gly–Arg–Leu–Val–Leu–Arg,如序列表SEQID NO:1所示。
2.如权利要求1所述抗牙龈卟啉单胞菌及具核酸杆菌多肽在制备牙龈卟啉单胞菌及具核酸杆菌感染性疾病药物中的应用。
3.如权利要求1所述抗牙龈卟啉单胞菌及具核酸杆菌多肽在制备漱口水中的应用。
4.如权利要求1所述抗牙龈卟啉单胞菌及具核酸杆菌多肽在制备牙膏添加剂中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910649716.7A CN110272472B (zh) | 2019-07-18 | 2019-07-18 | 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910649716.7A CN110272472B (zh) | 2019-07-18 | 2019-07-18 | 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110272472A true CN110272472A (zh) | 2019-09-24 |
CN110272472B CN110272472B (zh) | 2020-09-15 |
Family
ID=67964722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910649716.7A Active CN110272472B (zh) | 2019-07-18 | 2019-07-18 | 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110272472B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002077183A2 (en) * | 2001-03-21 | 2002-10-03 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
CN102203121A (zh) * | 2008-08-29 | 2011-09-28 | 口腔健康澳洲私人有限公司 | 牙龈卟啉单胞菌感染的预防、治疗和诊断 |
CN104043100A (zh) * | 2014-07-13 | 2014-09-17 | 王学建 | 一种鼻涕虫蛋白在制备治疗哮喘药品中的应用 |
CN104710517A (zh) * | 2014-03-14 | 2015-06-17 | 首都医科大学附属北京口腔医院 | 一种多肽、其应用及包含该多肽的药物 |
CN105153285A (zh) * | 2015-09-17 | 2015-12-16 | 北京化工大学 | 抗菌肽 |
CN108704119A (zh) * | 2018-06-15 | 2018-10-26 | 安徽医科大学 | 一种杀灭口腔致龋菌及抑制牙菌斑形成的抗菌肽及其应用 |
-
2019
- 2019-07-18 CN CN201910649716.7A patent/CN110272472B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002077183A2 (en) * | 2001-03-21 | 2002-10-03 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
CN102203121A (zh) * | 2008-08-29 | 2011-09-28 | 口腔健康澳洲私人有限公司 | 牙龈卟啉单胞菌感染的预防、治疗和诊断 |
CN104710517A (zh) * | 2014-03-14 | 2015-06-17 | 首都医科大学附属北京口腔医院 | 一种多肽、其应用及包含该多肽的药物 |
CN104043100A (zh) * | 2014-07-13 | 2014-09-17 | 王学建 | 一种鼻涕虫蛋白在制备治疗哮喘药品中的应用 |
CN105153285A (zh) * | 2015-09-17 | 2015-12-16 | 北京化工大学 | 抗菌肽 |
CN108704119A (zh) * | 2018-06-15 | 2018-10-26 | 安徽医科大学 | 一种杀灭口腔致龋菌及抑制牙菌斑形成的抗菌肽及其应用 |
Non-Patent Citations (2)
Title |
---|
GIOVANNI CILIA等: "Antimicrobial properties of terrestrial snail and slug mucus", 《JOURNAL OF COMPLEMENTARY AND INTEGRATIVE MEDICINE》 * |
PARKS,D.H.等: "TPA: type I glyceraldehyde-3-phosphate dehydrogenase, partial [Firmicutes bacterium]", 《NCBI》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110272472B (zh) | 2020-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arora et al. | Antimicrobial activity of spices | |
El-Shouny et al. | Antimicrobial activity of pyocyanin produced by Pseudomonas aeruginosa isolated from surgical wound-infections | |
Arunachalam et al. | Studies on bioprospecting of endophytic bacteria from the medicinal plant of Andrographis paniculata for their antimicrobial activity and antibiotic susceptibility pattern | |
Al-Rasheed et al. | Crude extracts of epidermal mucus and epidermis of climbing perch Anabas testudineus and its antibacterial and hemolytic activities | |
KR0165132B1 (ko) | 포도상구균 항균제 | |
Yin et al. | A specific antimicrobial protein CAP-1 from Pseudomonas sp. isolated from the jellyfish Cyanea capillata | |
CN104177485B (zh) | 一种扬子鳄抗菌肽Alligatorin6及其应用 | |
CN110305193A (zh) | 一种抗牙龈卟啉单胞菌多肽及应用 | |
CN105963680A (zh) | 用于抑制/瓦解生物被膜的抑制剂及其应用 | |
CN104163861B (zh) | 一种爬行动物抗菌肽Alligatorin5及其应用 | |
CN100485038C (zh) | 小型化抗耐药金黄色葡萄球菌多肽及其应用与制备方法 | |
Chakraborty et al. | In vitro growth inhibition of microbes by human placental extract | |
Olofin et al. | Assessment of the antimicrobial properties of fractions obtained from bryophytes | |
Gharieb et al. | Efficacy of pyocyanin produced by Pseudomonas aeruginosa as a topical treatment of infected skin of rabbits | |
CN110272472A (zh) | 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 | |
Muslim | Improving of antibacterial activity for antibiotics by purified and characterized lectin from Acinetobacter baumannii | |
CN110317247A (zh) | 一种抗口腔致病菌多肽及应用 | |
CN110305194A (zh) | 一种抗菌多肽及应用 | |
Caputo et al. | Antimicrobial activity of a meat-borne Bacillus subtilis strain against food pathogens | |
CN103193877B (zh) | 一种蛋白质及其在制备抗微生物产品中的应用 | |
Tuan | Isolation and evaluation of antimicrobial activity of endophytic actinobacteria on May Chang tree (Litsea cubeba) against pathogenic bacteria causing diseases on common carp and tilapia | |
CN111378023B (zh) | 一种抗变异链球菌多肽及其应用 | |
Bais et al. | Antibiofilm activity of coelomic fluid from Holothuria scabra (sandfish) against extended spectrum beta-lactamase (ESBL) producing Escherichia coli | |
Khayoon et al. | Cleavage of Mucin by Partial Purified Protease Produced from Gastrointestinal Escherichia Coli A29 Isolated from Iraqi Patients | |
CN107365363A (zh) | 小分子多肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Zhongjie Inventor after: Gao Shegan Inventor after: Deng Bo Inventor before: Li Zhongjie Inventor before: Liu Qiwei Inventor before: Deng Bo Inventor before: Gao Shegan |
|
GR01 | Patent grant | ||
GR01 | Patent grant |